Persistence of IgG4 as a potential serological marker of disease activity in patients with epidermolysis bullosa acquisita treated with rituximab

1. Gordilho, J.O.
2. Miyamoto, D.
3. Maruta, C.W.
4. Santo, R.M.
5. Mahmoud, A.
6. Navarro-Rodriguez, T.
7. Werneck-Silva, A.L.
8. de Aguiar, L.M.
9. Borges, I.C.
10. Santi, C.G.
11. Aoki, V.